I have always hated taking Medicines. That’s Why I’m Building ESCA.

In 2019, I was asked to build the pharmaceutical distribution business at udaan.com. It was a high-stakes role in a high-impact sector – large, perennial & deeply entrenched in our lives. I had worked in generalist roles before, at places like Flipkart and Uber, but this was my chance to go deep into one category.

But personally, I almost declined.

Because I’ve always had a strange relationship with medicines.

They were bitter, scary, synthetic. I didn’t trust them, didn’t understand them, didn’t feel in control when I took them. For me, taking a pill wasn’t a cure. It was compliance.

Still, I said yes to the role. Because I wanted to learn. Because I believed discomfort could lead to clarity. Because I was curious about the healthcare system that billions relied on.

Working in pharma changed something in me.

I saw the sheer scale of what India has achieved in healthcare access. Medicines made at under ₹1. Distributed through 50,000+ stockists. Reaching over a million chemists and medical stores.

And I learned how this industry had contributed meaningfully to both India and the world.

But I also saw what was missing.

Most of the energy in pharma goes toward the supply chain and doctors. Not toward the person who actually swallows the pill.

Medicines are built for doctors to trust. Not for consumers to love.

I saw this gap not just in my work, but in my life. I struggled with migraines. And despite being surrounded by some of the most powerful pharma brands, I couldn’t find something that made me feel cared for, seen, or understood as a patient.

That contradiction never left me – Pharma, which was so close to me professionally, felt a lot distant personally.

This is where ESCA was born.

I wanted to build a company that puts the consumer at the heart of everyday health. A brand that helps people take better care of themselves and their loved ones, not just through products, but through clarity, trust, and simplicity.

ESCA stands for Empowering Self-Care.

Because I believe the future of health in India won’t just be driven by doctors, hospitals & chemists, but also by us, the consumers.

By people who want to take charge of their everyday well-being. By families who want to understand what they’re putting into their bodies. By individuals who want to feel better, not just get treated.

We’re building ESCA to serve this shift.

We’re starting with products. But we’re here for something bigger. To make health feel less like a system, and more like a service. Less intimidating, more empowering.

And we hope that our little effort will go a long way in not only making Indians Self-Dependent when it comes to daily health & wellness concerns, but also saves India INR 30,000+ Crores, which is spent in doctors visits, worsened health conditions & out of pocket expenditure, thus creating an inefficient healthcare system.

We are launching soon. Check us out at www.escahealth.com.

We are hiring our Founding Team. In case this chimes in with you, please do reach out to me: sanil@escahealth.com.

Journey to the Center of an Industry

Hi There

I am reigniting this blog with this post & once again I promise to myself, I am going to write. Write consistently that is.

In case you didn’t get a chance to grab who I am, here’s a quick edited snapshot of my working life (it is contextual to know this):

’11 – 14 : Intern to Full-Time Category Builder at Flipkart (Sports/Fitness & Office Supplies are my babies)
’14 – 17 : General Manager at Uber (An amazing ride building rides)
’17 – 18 : Few months of wandering & soul-searching.
‘18 – 19 : On-Premise Consulting Sprint in Iran at TAP30 (Look em up)
’19 – 22 : Built Pharma eB2B Distribution at udaan.com (Loved the industry)
’23 Onwards : Started Tinkering with Pharma

My journey in 2023 (after an extremely poor stint at a start up) started with searching answers to the fragmented nature of Pharmaceutical as a category,(udaan had given me a good glimpse into the structure) & that got me to the manufacturing set up in India, which was interesting to see. India is worlds 3rd largest pharmaceutical exporter by volume, and is home to 10,000+ Factories. Of these only 10% are governed by stringent quality norms, remaining are just not being governed and thus operating loosely. It took me 100+ in-factory visits across India to understand this. And I wanted to take on the mission of Improving the Quality of Medicines coming out of India. But I realised this is perhaps not the best place to start, for multiple reasons.

This followed on with multiple pivots across selling Generics & Quick-Commerce, only to do what the heart always wanted – Build a Large-Scale Impact Driven Brand.

And that brings us to today. Fortunately, I am finally in a place where I exactly know what I want to gun for. I am also joined in by my wife and my co-founder for this mission & this is what it looks like:

“Empowering India to Take Charge of Their Everyday Health.”

Why is this even important & what led me to this?
Having spent more than 5 years tinkering across Pharma as an industry, one thing was clear: The industry has done a tremendous job in ensuring the accessibility of medicines to every corner of India & the world. That is, Industry has built a robust distribution network, nurtured R&D Talent and effectively improved the price points. To make that happen, the industry has primarily focused on Doctors and Chemists and that was much needed based on India’s needs.

But in the process, I noticed gaps left behind – Biggest being, the industry hasn’t spoken directly to the customers, nor have they built with the customers. Thus for a myriad of health ailments that just need management, Indians like me don’t know what to do.

I have suffered from migraines over the last 10 years & I have not been able to find a way to manage them. No one in the healthcare ecosystem has helped me get to the answer. Google “migraine” and the first few results throw information from websites based out of US and Europe.

I saw similar story being repeated across my friends and family, who are either winging their ailment by suffering through it, or are trying various different routes like alternative medicines, therapies & lifestyle changes or are mixing coffee with paracetamol at home (don’t do this!).

That is the origin of ESCA Consumer Health. ESCA stands for Empowering Self-Care and that’s what we intend to do by building products that we can use to manage daily health ailments for ourselves and our loved ones.

And we intend to build differently – We intend to build directly with the customers and talk directly to the customers – a route not very well followed by the existing industry. We then go back to Doctors and Chemists and work with them. But our core TG, our core consumers, our core creators remain Customers. Everything flows from there. Well, honestly, that’s also the only way to create an impact in this industry or by building an innovative research first product, which unfortunately we don’t have the expertise to do today. But we hope to get there someday.

But why build a brand to do this?
One thing that became extremely clear while piloting from manufacturing to retailing, the most value created in this industry is by the Brands – Think of the difference companies like Sun, Cipla, Mankind have created for India. They sit right at the center of the pharma value chain & ensure that the customer is catered to in the best possible manner.

That and a small inspiration back in the day – In 2019 I got an opportunity to pitch udaan.com to Sun Pharma and that’s when I happen to read this amazing biography of a silent entrepreneur who built a multi-billion pharma empire from scratch.


This has already been a long post. But if you reached here, thanks! I will talk more about ESCA and our first brand in the subsequent posts.

Cheers!

Kind of Business I want to build

Broad Themes / Filters

1. Own The Entire Value Chain
 Fully Vertically Integrated on Both Supply & Demand Side.
2. Play booked – Scalable Globally.
3. Highly Sticky – High Repeat behavior thus High LTV.
4. Hit Under served Target Groups (by Tech & Biz Model)
Baby Boomers, Senior Citizens, Manual Labor – Industrial, Manufacturing & Agriculture Labor, Internet Workers – Lower CAC relatively.
5. Financially Robust – Target GMs : 40-70%, Negative Working Capital
6. Build for Value – Premium/Quality Products & Services at Reasonable Prices
7. Create an Eponymous Brand – A long-lasting Brand Name.
8. Phygital / Omni-channel Business – Solving for Value Chain Problems
9. AI Powered – Augmenting Human & Business capability to deliver better.
10. Data & Analytics Driven – Helps Patients & Businesses drive efficiency.
11. Large TAM, Large Impact Opportunity
12. 10x Better – Ability to monopolize & generate long term future cash flows
13. High Network Effects – Starting small to maximize network effects.
  Start Small & Narrow. Dominate this Small Market. And then Monopolize.
14. Strong Brand Name
15. Inherent Economies of Scale

10x BETTER: Invent Something New. Or Radically Change the Existing World.



Current Landscape
1. The main flow of drugs today is through B2B Channel i.e Pharma Co selling to Distributors and Distributors influencing Retailers or in some cases Pharma Co directing their workforce to influence Retailers directly. This is the current scaled model (about 5-6% of India Pharma Market by Value). There is no established player here but fragmented distributors, who do about XX Business?
2. The other channel that is upcoming is Direct to Customer either by staying online or by owning up the Distribution to Retail stack via COCO and FOFO Retail stores. Players like Jan Aushadhi

Trends

1. Trade Generics are steadily becoming a thing primarily capturing under served markets by Big Pharma Cos.

What should the End Goal Be?


What could be the best way to leverage Tech & Biz Model Innovation to meet this End Goal?
Are the current ways good?

What would be the competitive moats?

Why Now?

SECOND ORDER THINKING

Sales Efficiency via MR is dropping:
That’s a resounding yes by execs across the Pharma industry. Core reasons:
a. Genericized Market with little differentiation in the Product
b. Incentive Tightening leading to restrictions on competing commercially
c. Margin Pressures leading to commercial ineffectiveness

Question is how is that impacting the industry at large:
Sales/Marketing is one of the key Value Adds a Pharma companies does to get a brand out in the market. They spend about 20-40% of their top-line on this activity. Due to above factors, this spending on manpower isn’t yielding the results needed. Thus Pharma Cos will need to do two things in order to grow top-line:
+ Continue expanding REACH via MR to gain topline: This would mean spends
 continue being inefficient & with pricing pressures, margins taking a hit.
+ Make existing MRs more efficient: This means getting a deeper Share of
 Prescriptions of a Doctor.
+ Either cut down on MR : REACH becomes restricted as a result of this
+ Make existing MR more effective : SHARE OF WALLET becomes a key

CHIRATAE VENTURES


GEMBA Capital

David vs Goliath.

Bunch of things happened last few days:

Watched two awesome shows on Netflix (Highly recommended for both Entrepreneurs and otherwise):

a. Dumb Money
How Keith Gill made $34 Mn from his basement but more importantly victory of an individual amassing sentiments of the masses and winning against the big guys.

b. The Playlist
How Daniel Ek changed the course of Music Industry by holding a customer first belief & transforming the fabric of the industry.

And then I happened to meet an old friend and colleague from Flipkart who, among other things, reminded me of WHO I WAS and WHAT HAS GOTTEN ME HERE. I guess I knew it, but I needed someone to tell me that. Which is,
“You are an Aggressive guy – You are a Hustler, You Make Shit Happen. Why isn’t that reflecting in your actions over the last one year?”

But as I said, I guess I knew this. And I have deeply reflected on this over the last year of trying to make shit happen. And there’s just one reason that stands out: BELIEF & CONVICTION.

Finally, my potential co-founder came around and said that the problem I am going after is hard & meaningful.

All my previous stints have been high scale early stage start ups, where the belief was led by the founder, conviction was built by the early team. I went and built it for the businesses I was asked to manage. That wasn’t that difficult cause shit had been figured out. But when I am out to do my own thing, I need to have that ONUS of BELIEF & CONVICTION. And to build something meaningfully large and impactful, I think that’s the only ingredient I need.

With those conversations y’day & two amazing Netflix shows later, I think I now want to put my finger one BIG PROBLEM and solve the shit out of it –
AFFORDABLE, ACCESSIBLY & QUALITY HEALTHCARE – FROM INDIA, FOR INDIA AND TO THE WORLD. PATIENT-FIRST, PROFITS LATER. Everything needs to revolve around the Patients first – Cost, Access, Quality & Convenience.

TO DO–LIST:
1. Build a large meaningful business enthused with Passion & Objectivity.
2. Work & Surround myself with Believers & Passionate folks.
3. Obsess about the Problem.
4. First-Principles, From the Basic, Creative & Analytical Thinking.
5. Passion for Customers Health & Well-Being. Everything else secondary.
6. Go Big. Go Ambitious. Create Impact.
7. Talk to your Customers & Stakeholders Closest to your Customers.
8. Stand Up for Your Customers.

ANTI TO-DO
LIST:
1. Keep Profits beyond what is needed to sustain the venture & take it global.
2. Participate in any activity that bulges up the cost of healthcare.
3. Participate in any activity that moves dollars against the patients.
4. Simply replicate what Others have done. Not leverage Tech Deeply.
5. Trade off Quality against Cost.
6. Eliminate the stakeholders in the industry & not add value to them.
7. Solve everything in one go.
8. Solve Superficially. Not go deep and not solve it structurally.
9. Leverage tech to reduce employment opportunities.
10. Build a Business only to sell off.
11. Build a Transactional Business.
12. Work with Non-Believers or Skeptics.
13. Obsess about Competition or Solutions.
14. Not think from First Principles or Basics.
15. Waste Time at anything that doesn’t help the Patients.

So what brings in this BELIEF & CONVICTION:

1. IMPACT : India’s NCD burden is increasing by the day. Developing countries are following the suit. That trajectory in developed world hasn’t reversed due to the increasing medical inflation and there are underlying factors to that. So impact opportunity is huge.

2. MARKET : $11.7 Tn of Global Market. India stands at $0.4 Tn. Rest of the World at $0.2 Tn. The developing markets are growing faster, have bigger problems and have more opportunities for impact creation.

3. TECHNOLOGY: Healthcare is not leveraging technology as it should. Sure digitization is happening but technology isn’t transforming the fabric of healthcare. That’s gets me excited.

4. BLUE OCEANS: Business models in healthcare haven’t scaled the way AMAZON, UBER or AIRBNB have. The existing incumbents are too busy managing their own shit. Both these factors leave a lot of blue oceans that can be carved out of this massive industry.

5. ANTI-OPINIONS: The more someone discourages me to think disruptively, esp. folks from the industry and otherwise, the more it encourages me to go after shit. It’s like NOVAK DJOKOVIC – The more the tide is against him, the better he gets.

6. BELIEF IN SELF – The whole point of getting into this journey has been to do something massively impactful. I don’t want to just build another business. I don’t want to make some money and then go back become an apparent opinion leader in random forums. I WANT THE WORLD TO CHANGE FOR BETTER. And I that’s the True Test of my True Potential. I want to play against the GOLIATHS & show them the value I can add to Customer & them simultaneously. My strengths are: Aggression, Risk Taking, Creative Mindset, Hustling Mindset, Passion, Energy, Ability to induce that energy into others & I want to double down on that for the next decade of my life. While cushioning myself against my weaknesses.

Writing this blog post is one of the reasons to do that, so that on the day I am feeling down & lose myself, I come back to this post and remind myself WHO I REALLY AM.

So I am TAKING TWO MASSIVE GOALS UPON MYSELF:

1. Play in the $11.7 Tn HEALTHCARE Market. Build something impactful.
2. Play TENNIS Competitively in Nationals.


Here are some pieces to remind me of that:

Everyone Has a Plan Until They Get Punched in the Mouth…

That’s a famous quote by Mohammed Ali & that is sort of chiming in my head today. I happened to meet someone in the industry I respect a lot and while my objective was to understand his thoughts about what I am doing and learn from it, it still sort of left an empty feeling in my stomach. And when I try to place that emotion into words, I realize I have been punched by my own expectations.

The thing about expectations is that that’s a product of thinking & unless the product is backed by concrete data points, it is often a hit or a miss. When it’s a hit, one calls it luck. In order to balance these expectations out, one has to put in hard effort. One has to have relevant data points & exposure (which over a period of time takes the form of intuition or gut), else it’s just a gamble. Thus, gamble it was today when I went into the meeting & expected to blow his mind out (I am a Sales/BD guy at heart after all and I guess that person inside me calls this out, which is fair). THAT DID NOT HAPPEN. Though I walked out with some good food for thought, but it reminded me of the quote I read this morning:

“The world will ask you who you are, and if you don’t know, the world will tell you.” — Carl Jung

At my own peril of asking, told I was.

The point I am making is: Luck does exist. I have been lucky quite a few times in life and for some of those times, I can’t place my finger on what it was. But most of the other times when I have been expecting magic without preparation, I have been left disappointed.

So here were my takeaways from the meeting today:

1. Don’t expect a win until you have displayed legitimate action to back your senses.That’s not being lucky. That’s just being hopeful.

2. Opinions are opinions. And the more you are unsure about yourself & your work (which is sort of fair at early stages), the more these opinions will keep playing. Trick is to take the learning out of the opinion, trust where the person is coming from and then channelize it to your advantage. This is easier said than done.

3. Approval is not your end goal, & should never be. Approval from customers should of course be your end goal. It’s a good to have. Good to haves, if not met should have no bearing on your overall goal. That’s the point of good to haves. You see if it works or not and move on.

4. BEHAVIOR CHANGING businesses can become hugely disruptive, high scale businesses. This is one of the pieces that came out in the discussion today & I have no reason to disagree to that. At Uber, we built a world that changed the way transportation worked. This was 2014 and drivers weren’t even accustomed to using smartphones. We gave them iPhones, in actuality, we gave them a new way to earn income. The rest is history.

5. Be Aware. It’s okay to plan such meetings to collect both feedback & opinions. However, do keep in mind why you are going into that meeting, keep in mind that earlier the stage, more opinionated the meeting, thus either you prepare thoroughly to rebut/convince the other person of your conviction or be ready to be slayed. Every meeting with someone respectable from the industry is a test of my conviction.

6. When punched in the face, GET UP & HAVE A GO AT IT AGAIN. After all,
  More the punches, more the failures.
  More the failures, more the learnings.
  More the learnings, more the strength.
  More the strength, more the character.
  More the character, more the success.

Cheers!





Remember, Remember… (When in Doubt)…

#backtobasics #firstprinciples

YC is a great institution that has cranked out some of the most amazing start ups in the world. And YC is also great at sharing some great advice. So here’s a notes to self sort of a list of things reproduced from YC’s Essential Start Up Advice.

  1. Perfection is neither an end state nor a means to an end state.
    • LAUNCH the Product right away, with basic minimum value to the customer.
    • LEARN from the Customers and understand their Pain Points better.
  2. Customers. Customers. Customers.
    • DO WHAT IT TAKES to get products to the customer. GET CUSTOMERS.
    • This doesn’t need to be a scalable or at-scale GTM.
    • Follow the 90/10 Rule : A Way to solve 90% of Customer’s Problems with 10% of the efforts. Idea is to get into the Customers doorstep.
  3. The Main Thing is to keep the Main Thing the Main Thing.
    • LASER SHARP FOCUS on PRODUCT & CUSTOMERS.
    • Everything else is a distraction.
    • Main Thing is: LAUNCH Something, TALK to your users to see if it serves their needs, then TAKE FEEDBACK & ITERATE.
  4. Staying SMALL is Cool.
    • 10 Customers who love you are >>> 1000 Customers who like you.
  5. Monitor UNIT ECONOMICS like a Hawk.
  6. LESS is MORE.
    • Identify One or Two Key Metrics around which your entire work will revolve & evolve.
    • Jim Collins in “Good to Great” calls these the North star Metrics.
  7. YOU ARE THE CAPTAIN of the SHIP. Keep SAILING.
    • Core job as a founder is continuously righting a capsized ship.
    • Shit happens to all Start Ups, at all times.
  8. BE SELF-OBSESSED, BE COMPETITION AWARE, not OBSESSED.
    • Competitive dynamics don’t matter in Year One or Two of your Start up.
  9. VALUATION is NOT EQUAL to SUCCESS or PROBABILITY OF IT.
    • Having MONEY is the Key.
      • Some of Y Combinator’s very best companies raised on tiny initial valuations (Airbnb, Dropbox, Twitch, are all good examples)
  10. TAKE CARE. BE NICE, BE KIND.
    • Take Breaks, Spend time with Family, Spend time on Leisure Activities, Exercise, Eat Right & GET ENOUGH SLEEP.
    • Be Nice & Be Kind to people you work with – Co Founders, Partners, Employees, Investors.

      Here’s another list summarized by Jen Abel I got off LinkedIn (that originally inspired me to pen this down), that is worth a read. My favorite points :

    • 0-1 sales talent does not exist. Founders, this is you. A seed-stage startup should never have a VP of Sales.
    • Product/market fit is almost always found in adjacent markets. Don’t handcuff yourself to Day 1 market vision.
    • The demo should never be focused on the product. 
    • You need to understand their buying process before you build your GTM.
    • Specificity is fastest way to build market trust. “Wow, I feel like this was built just for me.” 
    • The quality of your questions is critical for discovery; the quality of their questions is critical for intent. 
    • Your niche is not a random starting point. It’s a GTM strategy to prove the experiment.
    • Give yourself 18-24 months in the market to be invalidated, rejected, and redirected.
    • Consistency is the only way to unlock repeatable themes. Controlled conversations (i.e., experiments) are critical. 
    • 80% of early sales is getting them excited by YOU, the Founder — how you see the world and how you uniquely solve their specific problem. The product is the other 20%.
    • Some of the best wedge strategies target an uneconomical use case for incumbents.
    • If the primary need is being over-served, focus on the secondary need.
    • Someone asking for more features is never an early adopter.
    • Speed to respond to a prospect/customer is critical — be attentive.

The Growth of Trade Generics

I am quite curious to know:

1. Where is the higher growth for Trade Generics coming from – Customer Segments, Geographies, Disease Areas? My thesis is most of this is coming from Uninsured Middle Income Patients & Elderly Patients, primarily residing in Tier 2 & 3 Cities of India. Here are some numbers BARD threw out for me:

  • A 2023 Nielsen study highlights that middle-income households contribute almost 50% of the overall healthcare expenditure in India, emphasising their importance as a target segment for affordable medicines.
  • A 2022 report by IMS Health shows that the rural healthcare market in India is expected to reach $3.7 billion by 2025, reflecting significant potential for trade generics penetration.
  • A 2021 study by FICCI reveals that the elderly population in India is projected to reach 24% by 2030, indicating a growing need for cost-effective medication options.
  • A 2023 report by Invest India identifies tier-2 and tier-3 cities as key drivers of pharmaceutical market growth, presenting an ideal market for trade generics.
  • A 2022 report by AC Nielsen highlights the rising demand for affordable medicines in cities like Lucknow, Kanpur, Jaipur, and Indore, aligning with their potential for trade generics growth.
  • Disease Areas like Cardio-Vascular, Diabetes, Gastro, Pain, Respiratory are spot on areas for Trade Generics to Penetrate into.

2. Which are the companies that are tapping into this segment? What potential does this segment hold for the Indian & Developing Countries? Cipla, Alkem, Leeford have led the mission, with DRL, Torrent & more jumping into the fray.

3. Why are Pharma Companies tapping into this segment NOW? Pharma companies are increasingly tapping into trade generics because of the promising market size, potential for higher margins, regulatory support, changing consumer prefs, and the need to diversify their portfolios in a cost-sensitive market. The current environment in India presents a unique opportunity for companies to ride this wave of growth and establish themselves in a rapidly evolving segment.
Pharma companies are most likely taking a bet with a lower margin portfolio since it gets them access to the larger India i.e. Volumes making up for Value. 

If this indeed is true, then it will be interesting to ask: “How have other Deep Distribution plays such as FMCGs managed to penetrate into India?”

4. Do this address some of the key issues in Indian Pharma – Access & Availability (Affordability is a given due to the nature of trade here)? If yes, How?

Some facts:

  • Non-communicable diseases (NCDs), such as heart disease and cancer, cause 63% of all deaths in India. They are also expected to cost India $3.55 trillion in lost economic output between 2012 and 2030. 
  • In terms of prevalence, hypertension, diabetes, and cardiovascular disease are the leading NCDs with close to:
    • 242 Mn People (17% of Pop) suffering from Hypertension
    • 100 Mn People (7% of Pop) suffering from Diabetes
    • 70 Mn People (5% of Pop) suffering from Cardio Vascular condition
    • This is followed by Arthritis, Asthma & COPD.
  • Key Drivers:
    • Genetics
    • Lifestyle
    • Rapid Urbanization
    • Stress
  • A Chronic Patient’s journey includes:
    • Consultations & Follow Ups with Doctors
    • Regular Monitoring of Vitals – Through Device and/or Diagnostics
    • Purchasing Medicines & Health/Wellness Supplements/Food Items
    • Making Lifestyle Changes – Dietary & Exercise
    • Pain Points: Delay in Doctor Guidance & Expenditure of Managing the Condition

References:

https://health.economictimes.indiatimes.com/news/industry/digital-approach-may-help-tackle-rising-chronic-disease-cases-in-india-report/92433953

https://www.business-standard.com/industry/news/trade-generics-growth-to-dent-value-expansion-of-domestic-drug-market-123122500460_1.html

My Maiden Start Up Attempt – pharma.tech

Let’s click see if the link we hustled up is still alive: http://pharma.tech/ 

Nonetheless, here are some glimpses:

The idea behind pharma.tech was to connect Pharma Marketers with Manufacturers across India. The power of tech would be unleashed to curate the quality of manufacturers across the world and connect them with buyers who are seeking an efficient, cost effective and high quality service. We travelled length and breadth across India meeting manufacturers of all kinds and sizes & were fascinated to see how fragmented that landscape was.

India is the pharmacy of the world for that very reason – Availability of Good Resources! However, India needs to upgrade itself if it wants to meet the demand for its own sake and for rest of the world. The key is to curate the quality of production esp. when it comes to medicines & given India’s regulatory regime, that is the achilles heel. So the questions really are:

1. Can the power of Tech be used to unleash Quality Control of India’s & Developing countries Pharma Manufacturing at Scale?
2. Can this Quality Assurance become a Selling Point to Indian & Global Pharma companies?
3. Can this quality come at an efficient cost?
4. How can tech fly all the way to the source of Raw Materials and work it’s way upto Manufacturing and Distribution of medicines in the country?

While we shuttered this attempt primarily with the reasoning of not being able to find enough value, I reckon the reason was not being able to create enough value and be motivated to persevere in that attempt.

What do I believe in?

“Energy can motivate, but it takes belief in something bigger to inspire.” – Simon Sinek

Date: 21 Dec 2023, Finished on 29 Dec 2023
Venue: A Cozy Cafe in Gurgaon

An interesting quote that showed up in my inbox this morning. This made me think whether it is the Belief in the Mission that is missing from my entrepreneurial story. Cause after all my belief says that it is the Duty of the Entrepreneur / Founder to think of how to shape up the world & get Believers who believe in that belief. So let me try & address this very question, while I sit in this cozy cafe tucked away in Palam Vihar, Gurgaon. Might just find that belief that would inspire me to build.

Everyone says building in healthcare is tough. There hasn’t been a strong precedent in this category except perhaps Practo, 1MG & Pharmeasy. And then there are B2B Plays such as Indegene & THB.

Question arises: Why do I want to build in Healthcare? Here are my reasons:

1. Deep Problem Statements for a Developing Country like India – Quality, Accessibility, Affordability,Availability, Care

2. No Visible Innovation driving improvements on the above challenges for patients. Or at least that’s how it looks like to me.

3. No Massive UBER, Flipkart or AirBnB type Scaled start up making a dent

4. My own background in Healthcare over the last 4-5 Years

All of these factors make for a very compelling case to create a MASSIVE IMPACT w/ a High Return, High Reward Opportunity. 

Next question arises though, why hasn’t anyone been able to make a Deep Impact here! That’s an answer I don’t have yet in totality. But that’s okay. After all, entrepreneurship for me is an adventure and I am ok if I don’t scale Mount Everest at the end of the day, but I definitely have the spirit to get up there. And that journey I want to enjoy. So, what makes me enjoy that journey:

1. Good People to work with – By having an impactful mission that attracts adventurous talent.
2. Meeting Lot of People -Having a multi-geography business meets that goal
3. Seeing Scale i.e. Improving People’s Lives – Large TAM, Large Goal, Large  Vision. Ok to start narrow & small though.
4. Winning over Failures – Business that allows for extensive experimentation, makes me fail & helps me win with my own Problem Solving & Hustling faculties.
5. Being Respected – Building HIGH IMPACT, HIGH SCALE, HIGHLY DIFFERENTIATED Biz.
6. Working on Something New – New is fun, new is exciting, new is adventurous. Newness could be a stakeholder, a location, a product or a  feature. 

This in itself becomes a qualifying criteria for a lot of ideas that I have tinkered with or that come along the way.

Frame-working this journey further, let me try to analyse it along the vectors of some known frameworks (Ikigai & Jim Collins’ Golden Circle) :

  • Passion – What would I enjoy? (tried to framework above)
  • Skill-Set – What would be I extremely best at?
    Sales, Business Development, Marketing, Problem Solving, Hustling, People, P&L.
  • Impact – What Does the World Need? Does the Thesis fit the business need?
    Solving for Quality, Affordability & Availability is indeed High-Impact.
  • Economic Engine – What would unlock wealth for business? How would market size & monetisation look like?
    Market Size of $50Bn growing to $130Bn by 2030
  • Execution – What resources I have to get things up & running? 
    Experienced Colleagues, Industry Connects, Loving Mentors

Need to noodle over this evaluation grid. But I think the answer in my head is split into a bunch of areas: Healthcare (Pharma), Travel (Leisure).

In the meanwhile, here’s a quote I read this morning that hit my heart:

“Passion follows Commitment“

 So with all the above put in perspective, what would I remain committed to for the rest of my life? Guess only ACTION will tell. So STOP Writing & START Taking Action.

Create your own website, free on WordPress.com.Create your own website.
Start free